MIAMI, Jan. 10, 2017 /PRNewswire/ -- World Media & Technology Corp. ("Wor(l)d") (www.worldmediatech.com) (OTC PINK: WRMT), today announced that its research activity generating non-invasive, continuous blood glucose estimates has been found to be sufficiently accurate to allow WRMT to proceed to full integration of the algorithm in the Helo platform so WRMT can offer blood glucose estimation as a service in Q4'17 to Helo wearers who choose to pay an initial set-up fee and an ongoing monthly charge.
According to the International Diabetes Federation, 415 million people worldwide (1 in 11 people) have diabetes consuming 12% of global health expenditure ($673B) in 2015. The American Diabetes Association advises that in the US, nearly 30 million (1 in 8) people have diabetes and $1 in $5 health care dollars is spent caring for people with diabetes. Americans with diagnosed diabetes incur average medical expenditures of about $13,700 per year, of which about $7,900 is attributed to diabetes.
The importance of blood glucose (blood sugar) monitoring is the main tool used to check diabetes control. The current mainstream blood glucose measurement process is to use a lancing device on the side of the fingertip to get a drop of blood, touch the test strip to the drop of blood, and wait for the result. Apart from being painful for the diabetic, there are health risks due to the invasive nature of the process as well as measurement compliance and recording issues.
Helo's features today include measurement of Blood Pressure, ECG, Heart Rate, Respiration Rate, Heart Rate Variability (HRV) analysis for mood and energy levels along with measuring steps, distance and calorie burn. However, this is the first time anyone has used a photoplethysmograph (PPG) to estimate blood glucose levels and incorporate the technology into a wearable device to provide convenient, non-invasive blood glucose estimation and logging on a continuous basis.
Helo is not a medical device, but continuous measurement of blood glucose estimates are expected to be helpful in understanding blood glucose changes over time, aid compliance and support a pre-diabetic seeking to change their lifestyle to avoid diabetes.
WRMT's blood glucose estimation service is non-invasive, and can be scheduled to record blood glucose estimates routinely with readings stored in Helo's LifeLog for easy presentation to the diabetic's health care provider. In the event that Helo detects a blood glucose problem, Helo's Guardian service will automatically alert the wearer and their care giver. It is expected that this service will initially be available in Q4'17, to all Helo wearers who opt-in for the service and who pay the initial fee to cover registration and to start blood glucose monitoring.
Fabio Galdi, CEO, World Media & Technology Corp., said, "I am personally excited by this development. It is the first time that I am aware that PPG technology has been used to estimate blood glucose in a wearable device designed for the consumer wellness market. It will address a very real, painful and expensive need. Our test results have proven consistent with traditional blood glucose measurements so we have decided to start integration to provide this as a full Helo service later this year." He continued, "By the time that we launch, we will have enough Helo wearers all over the world to generate a very valuable blood glucose data base. Our plan is to share this data via our Big Data Portal with appropriate research partners. We are sure that together we can gain valuable insights and who knows, maybe somewhere, buried below all that data our research partners may find the cure for diabetes!"
About Wor(l)d
World Media & Technology Corp. designs, manufactures and sells connected, next-generation, innovative wearable devices which use its proprietary Life Sensing Technology. It has end-users in over 80 countries which it supports through its exclusive distribution partnership with Wor(l)d Global Network (www.worldgn.com). For further information, see www.worldmediatech.com.
This press release contains forward-looking statements. Words such as "expects," "intends," "believes," and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, the ability to secure additional sources of finance, the ability to reduce operating expenses, and other factors described in the Company's filings with the OTC Markets Group and with the SEC. The actual results that the Company achieves may differ materially from any forward-looking statement due to such risks and uncertainties. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/launch-of-worlds-first-wearable-non-invasive-continuous-blood-glucose-estimation-technology-using-wrmts-smart-wristband-helo-will-generate-recurring-revenues-for-wrmt-300388644.html
SOURCE World Media & Technology Corp.
Share this article